Clinical Trial Update: Tissue K+ in Primary Hyperaldosteronism

View source ↗

Summary

A clinical trial investigating tissue potassium in primary hyperaldosteronism has completed, sponsored by the University of Erlangen-Nürnberg Medical School.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Electrolyte Disturbance
• Hyperaldosteronism

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Primary Hyperaldosteronism, Electrolyte Disturbance | Status: COMPLETED